Used primarily in cancer research and therapy, this compound targets the interaction between p53 and MDM2 proteins, which is crucial in regulating cell growth and apoptosis. By inhibiting this interaction, it helps restore the function of p53, a tumor suppressor protein, in cancer cells where MDM2 overexpression often inactivates p53. This restoration can lead to the activation of apoptosis in cancer cells, making it a promising candidate for the development of anticancer drugs, particularly in cancers with wild-type p53. Its chiral nature allows for more precise targeting and potentially fewer side effects, enhancing its therapeutic efficacy.